中华老年医学杂志2024,Vol.43Issue(12) :1643-1650.DOI:10.3760/cma.j.issn.0254-9026.2024.12.021

降糖药物与老年肌少症的研究进展

The research progress on the antidiabetic agents related sarcopenia in elderly adults

李丹茜 张晓琳 周双 刘新民
中华老年医学杂志2024,Vol.43Issue(12) :1643-1650.DOI:10.3760/cma.j.issn.0254-9026.2024.12.021

降糖药物与老年肌少症的研究进展

The research progress on the antidiabetic agents related sarcopenia in elderly adults

李丹茜 1张晓琳 1周双 2刘新民1
扫码查看

作者信息

  • 1. 北京大学第一医院老年内科,北京 100034
  • 2. 北京大学第一医院药剂科,北京 100034
  • 折叠

摘要

肌少症是影响老年患者身体机能及生活质量的常见疾病之一.老年人群糖尿病患病率高,常存在多重用药,药物相关的肌肉损伤及肌少症发生风险大幅增加.因此,早期识别并替换高风险药物尤为重要.本文就可导致肌少症的降糖药物类型、作用机制、干预措施及药物管理进行综述,以促进老年人肌少症的防控、提高合理用药水平.

Abstract

Sarcopenia is one of the most common diseases of elderly patients which can affect the physical function and quality of life.Elderly patients not only have high prevalence of type 2 diabetes mellitus,but also have complex polypharmacy.As a result,the risk of antidiabetic agents related skeleton muscle damage and sarcopenia will increase significantly.Therefore,it is extremely important to identify and try to avoid the use of related drugs in the elderly.This article reviewed the types of antidiabetic drugs and mechanism likely leading to sarcopenia,as well as the intervention methods and drug management,to promote the prevention and control of the morbidity of sarcopenia in the elderly and improve the level of rational drug use.

关键词

糖尿病/肌肉损伤/肌肉减少症/降糖药/合理用药

Key words

Muscle damage/Sarcopenia/Diabetes/Antidiabetic agents/Rational drug use

引用本文复制引用

出版年

2024
中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
段落导航相关论文